Optinose Announces Reporting Date for Fourth Quarter and Full Year 2024 Financial Results

Provided By GlobeNewswire

Last update: Mar 11, 2025

YARDLEY, Pa., March 11, 2025 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced the Company will report financial results for the fourth quarter and full year of 2024 and corporate updates, before market open, on Thursday, March 20, 2025.